The growing field of biological therapy relies heavily on recombinant mediator technology, and a detailed understanding of individual profiles is paramount for optimizing experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, and IL-3 demonstrates notable differences in their struc… Read More